title: The CREATE Act: increasing costs associated with the biotech industry?
abstract: A new law intended to promote collaborative research may end up costing the biotech industry more and inhibiting innovation.
authors.affiliation: Program in Ethics and Policy in Health Care, Center for Biomedical Ethics, University of Virginia School of Medicine, P.O. Box 800758, Charlottesville, Virginia 22908, USA. amh2r@virginia.edu
authors.forename: Ann E
authors.initials: AE
authors.lastname: Mills
authors.forename: Donna T
authors.initials: DT
authors.lastname: Chen
authors.forename: John J
authors.initials: JJ
authors.lastname: Gillon
authors.forename: Patti M
authors.initials: PM
authors.lastname: Tereskerz
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence*; D007373:Interinstitutional Relations; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D018581:Technology Transfer; D014481:United States